Nov 10 2022
A new study provides evidence “supporting efficacy and tolerability of a full-spectrum, high-CBD product for anxiety.” Published in the journal Communications Medicine and conducted by researchers at Harvard Medical School, the study is titled Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. The study …
Nov 09 2022
33 Rhode Island cities voted yesterday on initiatives to allow marijuana businesses and sales within their jurisdictions, and a large majority were approved. In total 25 of the 33 cities voted in favor of allowing marijuana businesses to operate within the limits of the city. Specifically, voters were asked “Shall new cannabis-related licenses for businesses …
Nov 08 2022
An initiative to legalize marijuana in Missouri by establishing it as a constitutional right has been passed tonight by the state’s voters. Amendment 3 legalizes the purchase, possession, consumption, use, delivery, manufacturing, and sale of marijuana for all uses for adults who are at least 21 years old. In addition, the initiative allows individuals previously …
Nov 08 2022
Voters in Colorado have passed an initiative to legalize hallucinogenics including magic mushrooms, DMT and ibogaine. Proposition 122 legalizes the personal use and possession of several hallucinogenic/entheogenic plants and fungi for those 21 and older. Those include: dimethyltryptamine (DMT); ibogaine; mescaline (excluding peyote); psilocybin; and psilocyn.
Nov 08 2022
Maryland voters have given approval to an initiative to legalize marijuana for everyone 21 and older, making their state the 20th to do so. Question 4 amends the Maryland Constitution to add a new article, Article XX, which authorizes individuals 21 years of age or older to use and possess marijuana for all uses. The initiative …
Nov 07 2022
According to a study published in the peer-reviewed journal Cannabis and Cannabinoid Research and epublished ahead of print by the National Institute of Health, “medical cannabis may improve their quality of life and comorbidities” in those with Tourette’s syndrome. The study, titled Use of Medical Cannabis in Patients with Gilles de la Tourette’s Syndrome in …
Nov 07 2022
Cannabidiol (CBD) may alleviate liver and skin fibrosis according to a new study published by the peer-reviewed journal Frontiers in Pharmacology. “Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases”, states the study’s abstract. “Cannabidiol was demonstrated to reduce alcohol-induced liver inflammation and steatosis but its specific activity on the …
Nov 05 2022
According to new study published in the peer-reviewed journal Pain Practice and epublished by the U.S. National Institute of Health, cannabis may play a “significant role” in combatting treatment-resistant fibromyalgia in women. Fibromyalgia is a complex pain-focused syndrome, and previous studies “showed that Cannabis is efficacious in promoting sleep, deepening and lengthening the sleep cycle, …
Nov 03 2022
According to a new study published in the Journal of Clinical Medicine, “cannabis use was associated with a lower risk of hypertension and a lower number of metabolic disorders” among those with the Hepatitis C virus. For the study researchers examined the relationship between current and/or lifetime cannabis use and metabolic disorders in a cohort …
Nov 02 2022
A large majority of patients with Fragile X Syndrome reported that CBD improved some of their symptoms and “made a positive difference overall” in a new study. The study was published in the journal Genes as well as on the website for the U.S. National Library of Medicine, and is titled Parent and Caregiver Perspectives …
